Agenda
The following times listed are all indicated in Pacific Standard Time (PST).
Wednesday | January 31, 2024
|
|
---|---|
8:30 am | Registration and Coffee |
9:00 am | Welcome Remarks (James Doroshow, Michael Jackson) |
9:10 am | James H. Doroshow M.D. Rare Cancer Models for Therapeutic Development Director of the Division of Cancer Treatment and Diagnosis, National Cancer Institute |
9:40 am | Ben Cravatt, Ph.D. Activity-based proteomics - cancer target and ligand discovery on a global scale Professor, Chemistry, Scripps Research |
10:10 am | Anthony Pinkerton, Ph.D. Synthetic lethality in a plastic genome: Overcoming extrachromosomal DNA and oncogene amplification to address unmet needs in cancer Senior VP, Chemistry, Boundless Bio |
10:40 am | Coffee Break |
11:10 am | Fleur Ferguson, Ph.D. Interrogating the druggable proteome with proximity pharmacology Assistant Professor, Skagg School Pharmacy and Pharmaceutical sciences, UCSD |
11:40 am | Ray Deshaies, Ph.D. New frontiers in small molecule drug discovery Snr VP Global Research, Amgen |
12:10 pm | Lunch |
1:10 pm | Tom Miller, Ph.D. AI-driven discovery of 1000-fold selective and CNS-penetrant Her2 inhibitor CEO Iambic Therapeutics |
1:40pm | Sanju Sinha, Ph.D. DeepTarget: Predicting in-depth mechanism of actions for small molecule inhibitors Assistant Professor, SBP Cancer Center |
2:10 pm | Stephen Worland, Ph.D. STRIs: A New Class of Cancer Therapeutics that Regulate Gene Expression at the Step of RNA Translation CEO, eFFECTOR Therapeutics |
2:40pm | Coffee Break |
3:10 pm | Susanne Heynen-Genel, Ph.D. (Director, High Content Imaging Platforms, SBP) High-throughput phenotypic screening - a path to novel cancer therapeutics |
3:40 pm | Matt Hall, Ph.D., Director, Early Translational Branch, NCATS, and Jennifer Cox, Ph.D., Executive Director, Biology, Chinook From cancer to rare disease: The pre-clinical development of lactate dehydrogenase inhibitors |
4:10 pm | Reuben Shaw, Ph.D. Targeting autophagy to treat cancer Professor, Molecular and Cell Biology Laboratory Director, Salk NCI-Designated Cancer Center |
4:40 pm | Networking and Poster |
6:00 pm | Adjourn Meeting |